Techcyte, a leading provider of AI-powered digital solutions for anatomic and clinical pathology, today announced that it has received official  confirmation of UKCA UK Conformity Assessed) registration for several of its laboratory solutions, enabling the company to market them in the  United Kingdom.

UKCA (UK Conformity Assessed) marking is the United Kingdomʼs product certification standard, replacing Europeʼs CE marking for most goods placed on the UK market following Brexit. It signifies that a product meets UK regulatory requirements for safety, performance, and quality,  essential for laboratory solutions being used in Great Britain (England, Scotland, and Wales).

“We are excited to expand access to our platform in Great Britain,ˮ said Ben Cahoon, CEO of Techcyte. “Receiving UKCA registration is an  important step in our mission to deliver innovative, AI-powered solutions designed to help laboratories increase efficiency and improve their workflows.ˮ

Apacor, Techcyteʼs Expert Solution Provider (ESP) distributor in the UK, will support the availability of these newly registered solutions, which  include:

• Gram stain solution
• Wet mount iodine solution
• Acid-fast bacilli (AFB) solution
• Techcyte SureView™ Cervical Cytology System
• The Techcyte Fusion® AI & workflow platform

“We are proud to be the exclusive distributor for Techcyte in the UK,ˮ said Anthony Bellm, CEO of Apacor. “We are excited to make Techcyteʼs  solutions available to UK laboratories and support their transition to more efficient and modern workflows.ˮ

In addition to its newly granted UKCA registration, Techcyte holds CE markings for several solutions in Europe and is ISO 13485 certified,  underscoring its commitment to meeting rigorous international quality and regulatory standards.